Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin

Journal of Thrombosis and Thrombolysis

Volumn 24, Issue 3, 2007, Pages 225-232

  Hyers, Thomas M ^a,d   Spyropoulos, Alex C ^b,c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOVELACE MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d CARE Clinical Research   (United States)

Author keywords

Low molecular weight heparin; Out patient treatment; Venous thromboembolism

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BLEEDING; CLINICAL TRIAL; COMMUNITY CARE; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG MEGADOSE; DRUG OVERDOSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; EAR DISEASE; ECCHYMOSIS; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HEMATURIA; HOME CARE; HUMAN; INJECTION SITE CONTUSION; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; MULTICENTER STUDY; NEUTROPENIA; OUTPATIENT CARE; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECTUM HEMORRHAGE; RECURRENT DISEASE; SIDE EFFECT; SINGLE DRUG DOSE; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHLEBITIS; TREATMENT DURATION; VAGINA BLEEDING; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HOME CARE SERVICES; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; OUTPATIENTS; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; SELF ADMINISTRATION; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; WARFARIN;

EID: 35448933150     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0020-1     Document Type: Article

References (30)

1. Hull RD, Raskob GE, Pineo GF, Green D, Trowbridge AA, Elliott CG et al (1992) Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 326:975-82
2. Simonneau G, Sors H, Charbonnier B, Page Y, Laaban J-P, Azarian R et al, for The Thésée Study Group (1997) A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 337:663-669
3. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J et al (1996) A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334:677-681
4. Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Brandjes DPM, van der Meer J et al, for the Tasman Study Group (1996) Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334:682-687 (original); 1997; 337:1251 (correction)
5. Tillman DJ, Charland SL, Witt DM (2000) Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization. Arch Intern Med 160:2926-2932
6. Dedden P, Change B, Nagel D (1997) Pharmacy-managed program for home treatment of deep vein thrombosis with Enoxaparin. Am J Health Syst Pharm 54:1968-1972
7. Groce JB III (1998) Patient outcomes and cost analysis associated with an outpatient DVT treatment program. Pharmacotherapy 18:175S-180S
8. Pearson SD, Blair R, Halpert A et al (1999) An outpatient program to treat DVT with LMWH. Eff Clin Pract 2:21-217
9. Boccalon H, Elias A, Chaléne A et al (2000) for the Vascular Midi-Pyrenees Network Group. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin. Arch Intern Med 160:1769-1773
10. Ting SB, Ziegenbein RW, Gan TE et al (1998) Dalteparin for DVT: A hospital-in-the-home program. Med J Aust 168:272-276
11. Lindmarker P, Holmström M (1996) Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. J Int Med 240:395-401
12. Spyropoulos AC, Hurley JS, Ciesla GN et al (2002) Management of Acute Proximal deep vein thrombosis: Pharmacoeconomic evaluation of outpatient treatment with Enoxaparin vs inpatient treatment with unfractionated heparin. Chest 122:108-114
13. Chong BH, Brighton TA, Baker RI et al (2005) Once-daily Enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis. J Thromb Thrombolysis 19:173-81
14. Harrison L, McGinnis J, Crowther M et al (1998) Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med 158:2001-2003
15. Kovacs MJ, Ander D, Morrow B et al (2000) Outpatient treatment of pulmonary embolism with Dalteparin. Thromb Haemost 83:209-211
16. Wells P, Kovacs MJ, Bormanis J et al (1998) Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin. Arch Intern Med 158:1809-1812
17. Bishop B, Wilson AG, Post D et al (2006) A pilot study of home treatment of deep vein thrombosis with subcutaneous once-daily enoxaparin plus warfarin. J Manag Care Pharm 12:70-75
18. Ramacciotti E, Araújo GR, Lastoria S et al (2004) An open-label, comparative study of the efficacy and safety of once-daily dose of Enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis. Thromb Res 114:149-153
19. Wells PS, Anderson DR, Rodger MA et al (2005) A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Arch Intern Med 165:733-738
20. Tapson VF, Hyers TM, Waldo AL et al (2005) Antithrombotic practices in U.S. hospitals in an era of practice guidelines. Arch Intern Med 165:1458-1464
21. Schwarz T, Schmidt B, Beyer J et al (2001) Eligibility for home treatment of deep vein thrombosis: A prospective study in 202 consecutive patients. Vasc Surg 34:1065-1070
22. van den Belt AGM, Bossuy PMM, Prius MH et al (1998) Replacing inpatient care by out-patient care in the treatment of deep venous thrombosis: An economic evaluation. Thromb Haemost 79:259-263
23. Gould MK, Dembitzer AD, Sanders GD, Garber AM (1999) Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: A cost-effectiveness analysis. Ann Intern Med 130:789-799
24. O'Brien B, Levine M, Willian A, Goeree R, Haley S, Blackhouse G et al (1999) Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis. Arch Intern Med 159:2298-2304
25. Hull RD, Raskob GE, Brant RF, Pineo GF, Elliott G, Stein PD et al (2000) for the American-Canadian Thrombosis Study Group. Low-molecular weight heparin vs heparin in the treatment of patients with pulmonary embolism. Arch Intern Med 160:229-236
26. Quinlan DJ, McQuillan A, Eikelboom JW (2004) Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: A meta-analysis of randomized, controlled trials. Ann Intern Med 140:175-183
27. Lee AYY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M et al, for the Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349:146-153
28. Hull RD, Pineo GF, Brant RF et al (2006) Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med 119:1062-1072
29. Büller HM, Agnello G, Hull RD, Hyers TM, Prins MH, Raskob GE (2004) Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:401S-428S
30. Kearon C, Ginsberg JS, Julian JA et al (2006) Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular weight heparin for acute treatment of venous thromboembolism. JAMA 296:935-942